Uncategorized
Marlene Rabinovitch, M.D.
Marlene Rabinovitch, M.D. June 1, 2020 Dwight and Vera Dunlevie Professor of Pediatrics (Cardiology) Stanford University School of Medicine Stanford, CA Primary Research: Our research program seeks to identify the cellular and molecular programs that are dysregulated in vascular disease with a focus on pulmonary arterial hypertension (PAH). This condition can be a fatal complication…
Read MoreJulie A. Phillippi, Ph.D.
Julie A. Phillippi, Ph.D. May 1, 2020 Department of Cardiothoracic Surgery and McGowan Institute for Regenerative Medicine University of Pittsbugh Pittsburgh, PA Primary Research: The Phillippi Laboratory is focused on two primary objectives 1) Understanding the role of the microvasculature in cardiovascular pathologies; and 2) Developing novel technologies that therapeutically preserve or regenerate microvasculature. Active…
Read MoreWhat Chromatin Remodelers Can Teach Us About Vascular Development and Integrity
What Chromatin Remodelers Can Teach Us About Vascular Development and Integrity April 2, 2020 COURTNEY GRIFFIN, PH.D. Member Cardiovascular Biology Research Program Scientific Director Oklahoma Medical Research Foundation Took place on April 2, 2020 at 1:00pm EST THIS WEBINAR IS BEING SPONSORED BY BIOSPHERIX BioSpherix manufactures in vitro & in vivo equipment that helps researchers generate reproducible models with…
Read MoreAngela Glading, Ph.D.
Angela Glading, Ph.D. April 1, 2020 Department of Pharmacology and Physiology University of Rochester Rochester, NY Primary Research: Defective or improperly regulated adhesion is observed in a wide variety of human diseases, including the major killers cancer and cardiovascular disease. Research in the Glading lab focuses on unraveling how cell adhesion signaling regulates cellular behavior,…
Read MoreNew Insights into Lymphatics and Lymphatic-related Cells from the Zebrafish
New Insights into Lymphatics and Lymphatic-related Cells from the Zebrafish March 12, 2020 BRANT WEINSTEIN, PH.D. Associate Scientific Director NICHD, NIH Took place on March 12, 2020 at 1:00pm EST BRANT WEINSTEINÂ – Dr. Brant M. Weinstein received his Ph. D. from the Massachusetts Institute of Technology and carried out postdoctoral studies in the laboratory of…
Read MoreAmber Stratman, Ph.D.
Amber Stratman, Ph.D. March 1, 2020 Department of Cell Biology and Physiology Washington University School of Medicine St. Louis, MO Primary Research: My research group is interested in the mechanosensitive inputs that direct mural cell recruitment to arteries during development. We are particularly interested in how mechanosensitive proteins couple force inputs from a 3D environment…
Read MoreMural Cell SDF1 Signaling Is Associated with The Pathogenesis of Pulmonary Arterial Hypertension
Mural Cell SDF1 Signaling Is Associated with The Pathogenesis of Pulmonary Arterial Hypertension February 13, 2020 KE YUAN, PH.D. Associate Scientific Researcher and Member of the Faculty of Pediatrics Harvard Medical School Took place on February 13, 2020 at 1:00pm EST KE YUANÂ – Ke is currently an Assistant Professor in the Department of Pediatrics, Boston…
Read MoreRoger Johns, M.D., Ph.D.
Roger Johns, M.D., Ph.D. February 1, 2020 Department of Anesthesiology and Critical Care Medicine Johns Hopkins University Baltimore, MD Primary Research: We discovered hypoxia-induced mitogenic factor (HIMF) as an unknown gene in lung from a hypoxia model of pulmonary hypertension. This was subsequently found to be a member of the resistin-like family of chemokine growth…
Read MoreThe Gut-Brain Axis in Cerebral Cavernous Malformation
The Gut-Brain Axis in Cerebral Cavernous Malformation January 23, 2020 MARK KAHN, M.D. Professor of Medicine Division of Cardiovascular Medicine University of Pennsylvania Took place on January 23, 2020 at 1:00pm EST MARK KAHNÂ – Dr. Mark Kahn is a practicing cardiologist in the Division of Cardiovascular Medicine at the University of Pennsylvania. He has won…
Read MoreSara S. Nunes de Vasconcelos, Ph.D.
Sara S. Nunes de Vasconcelos, Ph.D. January 1, 2020 Division of Experimental Therapeutics Toronto General Hopistal Research Institute and University of Toronto Toronto, Ontario Canada Primary Research: Motivated by the need to generate alternative therapeutic avenues to treat cardiovascular diseases, my research interests involve the development of vascularization strategies in combination with human stem cell-derived…
Read More